Bernard Ravina is Chief Medical Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 99,476 shares of PRAX, which is worth approximately $4.11 Million. The most recent transaction as insider was on Feb 12, 2022, when has been sold 3,057 shares (Common Stock) at a price of $12.85 per share, resulting in proceeds of $39,282. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.5K
0% 3M change
0% 12M change
Total Value Held $4.11 Million

Bernard Ravina Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2022
SELL
Payment of exercise price or tax liability
$39,282 $12.85 p/Share
3,057 Reduced 2.98%
99,476 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
22,000 Added 17.67%
102,533 Common Stock
Feb 12 2021
BUY
Grant, award, or other acquisition
-
24,512 Added 23.33%
80,533 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$102,150 $2.27 p/Share
45,000 Added 44.55%
56,021 Common Stock
BR

Bernard Ravina

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on PRAX

Follow Praxis Precision Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

News

Receive news related to Praxis Precision Medicines, Inc.

Track Activities on PRAX